DONALD PARSONS to Treatment Outcome
This is a "connection" page, showing publications DONALD PARSONS has written about Treatment Outcome.
Connection Strength
0.043
-
Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions. Clin Cancer Res. 2025 Feb 03; 31(3):561-572.
Score: 0.019
-
Phase II study of peginterferon alpha-2b for patients with unresectable or recurrent craniopharyngiomas: a Pediatric Brain Tumor Consortium report. Neuro Oncol. 2020 11 26; 22(11):1696-1704.
Score: 0.014
-
Aurora kinase inhibitor nanoparticles target tumors with favorable therapeutic index in vivo. Sci Transl Med. 2016 Feb 10; 8(325):325ra17.
Score: 0.010